Latest Announcements

Mukka Proteins Limited has received an EU – Inputs Attestation from ECOCERT S.A.S., France, confirming that its product 'Eco Sphere Organic Fertilizer' is suitable for use in organic farming, subject to specific conditions. This is expected to enhance marketability and acceptance of the product in organic farming markets, including the European Union, and support the company's efforts to expand its value-added and sustainable product portfolio.

DCW Limited has received a favorable tax order from the Commissioner of Income Tax (Appeals) resulting in a reduction of Rs. 16.94 crores in the MAT credit and a corresponding reduction in tax liability and contingent liability of Rs. 11.99 crores.

CEAT Limited has informed the Exchange about an order issued by the Customs, Excise and Service Tax Appellate Tribunal, Mumbai, allowing the company's appeal and setting aside an earlier order imposing a fine and penalty on EPCG licences.

Karur Vysya Bank Limited has received a favourable order from the Hon'ble Income Tax Appellate Tribunal, setting aside the order passed by the Commissioner of Income Tax (Appeals) for the AY 2022-23 pertaining to FY 2021-22.

Tata Chemicals Limited has informed the Exchange regarding a press release dated September 01, 2026, titled 'CSIR-CSMCRI study finds Mithapur coastal ecosystem healthy and biodiverse following treated wastewater pipeline transition'. The study by CSIR-Central Salt & Marine Chemicals Research Institute, Bhavnagar, found the marine ecosystem surrounding Tata Chemicals Limited's (TCL) effluent discharge point at Mithapur to be healthy, stable, and productive.

Sun Pharmaceutical Industries Limited has announced its participation in a White House ceremony to highlight U.S. medicines pricing and access commitments. The company has agreed to extend Most Favored Nation (MFN) pricing to state Medicaid programs and commit to MFN pricing for future innovative medicine launches.

Star Cement Limited has informed the Exchange about General Updates regarding the amendment to the Mines and Minerals (Development and Regulation) Act, 1957, which restricts the imposition of taxes, cess, and other levies by State Governments on mineral rights or mineral-bearing lands. The Company and its subsidiaries are no longer required to pay Mineral Cess with effect from 22nd August, 2026.

CEAT Limited has received an Order-in-Appeal from the Commissioner (Appeals), CGST Thane Commissionerate, Mumbai, under the Central Goods and Services Tax Act, 2017, dismissing a demand of INR 107 Crore for the supply of Tube and Flap along with Tyre as composite supply.

CEAT Limited has informed the Exchange regarding 'General Updates' as the Competition Commission of India (CCI) has passed an Order dated August 21, 2026, in a matter relating to alleged bid-rigging in procurement tenders of State Transport Undertaking(s), finding no contravention on the part of CEAT Limited.

Lux Industries Limited held a press conference on August 21, 2026, to clarify allegations made by Mr. Kunal Ghosh regarding the clearance and approval-related matters associated with the 'Lux Cozi Group' project. The company's Chairman, Mr. Ashok Kumar Todi, briefed the media on the scale of investment and significance of the proposed capacity expansion of manufacturing capacities of Vertical A of the Company's at Dankuni. The company also issued a defamation notice to Mr. Kunal Ghosh.

Aurobindo Pharma Limited has informed the Exchange about the completion of a US FDA inspection at Auro Peptides Ltd, a subsidiary/business arm of the Company. The inspection concluded with only one observation, relating to facility and equipment maintenance, and corrective action was initiated during the inspection. The Company reaffirmed its commitment to maintaining robust quality and compliance standards across its manufacturing facilities.

Strides Pharma Science Limited has received the Establishment Inspection Report (EIR) from the USFDA for its flagship facility in Bengaluru, indicating successful closure of the inspection.

eMudhra Limited has informed the Exchange about the closure of a complaint by the Economic Offence Wing, Navi Mumbai Police Commissionerate in relation to allegations made by 3i Infotech Limited. The complaint was filed in February 2026 and was closed due to the matter being considered a civil dispute.

CL Educate Limited, the diversified education services group behind Career Launcher, DEXIT Global, and mySATHI Foundation, welcomed Prime Minister Narendra Modi's announcement of free online coaching for competitive examinations and a nationwide programme to train one crore youth in Artificial Intelligence over the coming year.

Sun Pharmaceutical Industries Limited has received a favourable court decision in the Lipitor antitrust litigation, with the US Court of Appeals affirming the order granting summary judgment in favour of the company and its subsidiaries, and denying class certification to the plaintiffs.

Dynamic Cables Limited has received a favorable order from the Office of the Commissioner (Appeals), Central Goods and Services Tax, Jaipur, under Section 107(11) of the CGST Act, 2017, allowing the Company's appeal and dropping the demand of Rs.3,28,030/- on account of non-payment of GST under the Reverse Charge Mechanism (RCM) for the financial year 2018–19.

Atlanta Electricals Limited has informed the Exchange regarding withdrawal of Debarment Order by South Bihar Power Distribution Company Limited (SBPDCL) due to the company's appeal and detailed submissions.

Wanbury Limited has received approval from the European Directorate for the Quality of Medicines and Healthcare (EDQM) for its new product Rivaroxaban API, and also received DMF clearance for Paraxetine HCI and Metformin HCI from the USFDA.

Imagicaaworld Entertainment Limited has informed the Exchange regarding disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Arbitration Award. The Arbitration award has been issued by Sole Arbitrator, Ld. Vijay C. Daga, Former Judge, Bombay High Court on 12.08.2026 in the matter of Bharat Lekhraj Harwani (“Claimant”) and Rajendra Ramvilas Jakhotia & Ors. (“Respondents), wherein Imagicaaworld Entertainment Ltd (“Company”) was also one of the respondents. The Arbitration award is favourable and has not imposed any liability on the Company.

Bajaj Healthcare Limited has received approval from the Drug Controller General of India (DCGI) to manufacture and market Cenobamate API and Tablets in six strengths, marking a significant milestone in the Company's journey towards bringing advanced therapies to patients.